Correlation of High-Resolution X-Ray Micro-Computed Tomography with Bioluminescence Imaging of Multiple Myeloma Growth in a Xenograft Mouse Model

od Postnov, Andrei A., Rozemuller, Henk, Verwey, Viviene, Lokhorst, Henk, De Clerck, Nora, Martens, Anton C.
Izdano 2009

Deazaneplanocin A Is a Promising Drug to Kill Multiple Myeloma Cells in Their Niche

od Gaudichon, Jérémie, Milano, Francesco, Cahu, Julie, DaCosta, Lætitia, Martens, Anton C., Renoir, Jack-Michel, Sola, Brigitte
Izdano 2014

Non‐invasive imaging of mouse hepatitis coronavirus infection reveals determinants of viral replication and spread in vivo

od Raaben, Matthijs, Prins, Henk‐Jan, Martens, Anton C., Rottier, Peter J. M., De Haan, Cornelis A. M.
Izdano u Cell Microbiol (2009)

The Impact of Cell Source, Culture Methodology, Culture Location, and Individual Donors on Gene Expression Profiles of Bone Marrow-Derived and Adipose-Derived Stromal Cells

od Torensma, Ruurd, Prins, Henk-Jan, Schrama, Ellen, Verwiel, Eugène T.P., Martens, Anton C.M., Roelofs, Helene, Jansen, Bastiaan J.H.
Izdano 2013

Differential Effects of Nitrostyrene Derivatives on Myelopoiesis Involve Regulation of C/EBPα and p38MAPK Activity

od Bartels, Marije, Calgarotto, Andrana K., Martens, Anton C., Maso, Victor, da Silva, Saulo L., Bierings, Marc B., de Souza Queiroz, Mary L., Coffer, Paul J.
Izdano 2014

Modifying Graft-versus-Host Disease in a Humanized Mouse Model by Targeting Macrophages or B-Cells

od Hogenes, Marieke C. H., van Dorp, Suzanne, van Kuik, Joyce, Monteiro, Filipa R. P., ter Hoeve, Natalie, Guedes, Liane, van Dijk, Marijke R., Martens, Anton C., de Weger, Roel A.
Izdano u J Immunol Res (2019)

Bone-Marrow-Derived Cells Contribute to Glomerular Endothelial Repair in Experimental Glomerulonephritis

od Rookmaaker, Maarten B., Smits, Anke M., Tolboom, Herman, van ’t Wout, Karin, Martens, Anton C., Goldschmeding, Roel, Joles, Jaap A., van Zonneveld, Anton Jan, Gröne, Herman-Joseph, Rabelink, Ton J., Verhaar, Marianne C.
Izdano 2003

Dll1 marks early secretory progenitors in gut crypts that can revert to stem cells upon tissue damage

od van Es, Johan H., Sato, Toshiro, van de Wetering, Marc, Lyubimova, Anna, Gregorieff, Alex, Zeinstra, Laura, van den Born, Maaike, Korving, Jeroen, Martens, Anton C.M., van den Oudenaarden, Alexander, Clevers, Hans
Izdano 2012

HuMab-7D8, a monoclonal antibody directed against the membrane-proximal small loop epitope of CD20 can effectively eliminate CD20(low) expressing tumor cells that resist rituximab-...

od van Meerten, Tom, Rozemuller, Henk, Hol, Samantha, Moerer, Petra, Zwart, Mieke, Hagenbeek, Anton, Mackus, Wendy J.M., Parren, Paul W.H.I., van de Winkel, Jan G.J., Ebeling, Saskia B., Martens, Anton C.
Izdano 2010

Optimal selection of natural killer cells to kill myeloma: the role of HLA-E and NKG2A

od Sarkar, Subhashis, van Gelder, Michel, Noort, Willy, Xu, Yunping, Rouschop, Kasper M. A., Groen, Richard, Schouten, Harry C., Tilanus, Marcel G. J., Germeraad, Wilfred T. V., Martens, Anton C. M., Bos, Gerard M. J., Wieten, Lotte
Izdano u Cancer Immunol Immunother (2015)

A Rational Strategy for Reducing On-Target Off-Tumor Effects of CD38-Chimeric Antigen Receptors by Affinity Optimization

od Drent, Esther, Themeli, Maria, Poels, Renée, de Jong-Korlaar, Regina, Yuan, Huipin, de Bruijn, Joost, Martens, Anton C.M., Zweegman, Sonja, van de Donk, Niels W.C.J., Groen, Richard W.J., Lokhorst, Henk M., Mutis, Tuna
Izdano u Mol Ther (2017)

N-cadherin-mediated interaction with multiple myeloma cells inhibits osteoblast differentiation

od Groen, Richard W.J., de Rooij, Martin F.M., Kocemba, Kinga A., Reijmers, Rogier M., de Haan-Kramer, Anneke, Overdijk, Marije B., Aalders, Linda, Rozemuller, Henk, Martens, Anton C.M., Bergsagel, P. Leif, Kersten, Marie José, Pals, Steven T., Spaargaren, Marcel
Izdano 2011

CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia

od Naik, Jyoti, Themeli, Maria, de Jong-Korlaar, Regina, Ruiter, Ruud W.J., Poddighe, Pino J, Yuan, Huipin, de Bruijn, Joost D., Ossenkoppele, Gert J., Zweegman, Sonja, Smit, Linda, Mutis, Tuna, Martens, Anton C.M., van de Donk, Niels W.C.J., Groen, Richard W.J.
Izdano u Haematologica (2019)

Sepantronium bromide (YM155) improves daratumumab-mediated cellular lysis of multiple myeloma cells by abrogation of bone marrow stromal cell-induced resistance

od de Haart, Sanne J., Holthof, Lisa, Noort, Willy A., Minnema, Monique C., Emmelot, Maarten E., Aarts-Riemens, Tineke, Doshi, Parul, Sasser, Kate, Yuan, Huipin, de Bruijn, Joost, Martens, Anton C.M., van de Donk, Niels W.C.J, Lokhorst, Henk M., Groen, Richard W.J., Mutis, Tuna
Izdano u Haematologica (2016)

Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma

od Drent, Esther, Groen, Richard W.J., Noort, Willy A., Themeli, Maria, Lammerts van Bueren, Jeroen J., Parren, Paul W.H.I., Kuball, Jürgen, Sebestyen, Zsolt, Yuan, Huipin, de Bruijn, Joost, van de Donk, Niels W.C.J., Martens, Anton C.M., Lokhorst, Henk M., Mutis, Tuna
Izdano u Haematologica (2016)

Complete Tumor Regression by Liposomal Bortezomib in a Humanized Mouse Model of Multiple Myeloma

od Deshantri, Anil K., Fens, Marcel H.A.M., Ruiter, Ruud W.J., Metselaar, Josbert M., Storm, Gert, Mandhane, Sanjay N., Graat, Gerard H.M., Lentjes, Eef G.W., Yuan, Huipin, de Bruijn, Joost D., Mutis, Tuna, Martens, Anton C.M., Groen, Richard W.J., Schiffelers, Raymond M.
Izdano u Hemasphere (2020)

PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formation

od Ren, Zhihong, Ahn, Jeong Hyun, Liu, Hequn, Tsai, Yi-Hsuan, Bhanu, Natarajan V., Koss, Brian, Allison, David F., Ma, Anqi, Storey, Aaron J., Wang, Ping, Mackintosh, Samuel G., Edmondson, Ricky D., Groen, Richard W. J., Martens, Anton C., Garcia, Benjamin A., Tackett, Alan J., Jin, Jian, Cai, Ling, Zheng, Deyou, Wang, Gang Greg
Izdano u Blood (2019)